FY26 Lab Consolidation for Coagulation CPRR Effort

The Department of Defense is issuing RFQ HT941026Q2004 for a Cost‑Per‑Reportable‑Result (CPRR) contract to provide coagulation analyzers and related in‑vitro diagnostic supplies to twelve designated military treatment facilities (including Naval Hospital Bremerton, Naval Hospital Camp Pendleton, JBER 673rd Medical Group, Luke AFB 56th Medical Group, Madigan Army Medical Center, Naval Medical Center San Diego Core Lab, and others). The contractor must support current workloads, submit monthly reports detailing test quantities performed at each site for invoicing, and be prepared to add additional MTFs via mutually‑agreed modifications. This unrestricted procurement (NAICS 334516, PSC 6550) is not set‑aside; quotes are due 1:00 PM PST on May 14, 2026. Offers will be evaluated on four factors: Technical approach, Past Performance (ability to deliver supplies on schedule), Information Assurance, and Price (including any options). Technical compliance is mandatory—quotes that do not meet all requirements will be deemed unacceptable unless no other technically acceptable offer exists. Information‑assurance requirements include demonstrating RMF compliance and the ability to undergo unrestricted automated scanning (ACAS/Nessus/SCAP) without impacting clinical workflow. Price will be assessed for reasonableness using standard price‑analysis techniques, and option pricing must be balanced.

Notice ID

dddb007d806f41529b5650c70255f205

Solicitation Number

HT941026Q2004

NAICS Code

334516

Classification Code

6550